MARIMED INC. Cash Flow Statement
MRMD|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
MARIMED INC. generated $8M in operating cash flow and $7M in free cash flow in FY2025. Free cash flow margin was 4.1% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$14.5M | -$12.5M | -$16.0M | $13.5M | $7.2M | $2.1M | -$81.2M | -$13.6M | -$1.2M | -$198.9K | -$1.8M | -$7.4M | -$535.6K | -$809.5K | -$377.4K |
| Depreciation & Amortization | $8.1M | $7.9M | $5.5M | $3.4M | - | $1.8M | $1.0M | $658.0K | $363.0K | $265.7K | - | - | - | - | - |
| Operating Cash Flow | $7.7M | $6.8M | $7.9M | $7.3M | $35.9M | $3.4M | -$24.1M | -$2.9M | $1.8M | -$197.9K | -$392.9K | -$455.2K | -$10.7K | -$127.5K | -$181.3K |
| Capital Expenditures | $1.2M | $12.0M | $20.1M | $12.1M | $17.9M | $4.7M | $9.7M | $8.9M | $21.0M | $3.4M | - | -$2.7K | - | - | - |
| Free Cash Flow | $6.5M | -$5.2M | -$12.2M | -$4.8M | $18.0M | -$1.3M | -$33.8M | -$11.8M | -$19.2M | -$3.6M | - | -$452.6K | - | - | - |
| FCF Margin | 4.1% | -3.3% | -8.2% | -3.6% | 14.8% | -2.6% | -74.1% | -99.8% | -316.6% | -99.9% | - | -512.0% | - | - | - |